Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Oppenheimer raises Tesla (TSLA) price target to $418 amid Q4’s positive Model 3 outlook

% of readers think this story is Fact. Add your two cents.


Wall Street’s sentiments towards Tesla (NASDAQ:TSLA) continues to get more positive, with Oppenheimer analyst Colin Rusch reiterating an “Outperform” rating on the company while raising his price target to $418 per share. Oppenheimer’s update comes amidst Tesla’s ongoing rally, which features the stock nearing levels close to its 52-week high of $387.46.

In a recent note to clients, Rusch stated that the drama surrounding Tesla and its CEO over the past few months seems to be all but over. This, according to the Wall Street analyst, places Tesla’s improving fundamentals front and center. Pushed by an even more optimized Model 3 ramp and weak competition from rival carmakers, Rusch notes that the next quarters could prove to be even better for the electric car maker.

“After a drama-filled fall that concluded with a settlement with SEC and a new board chair, we believe TSLA is enjoying improving fundamentals based on increasingly efficient manufacturing, strong ASPs leading to better than expected cash flow, as well as slow and disappointing competition entering the market for EV/ PHEVs,” Rusch said.

The Oppenheimer analyst notes that Tesla seems poised to top Wall Street estimates for 66,000 Model 3 production in the fourth quarter. Rusch also stated that Model 3 gross margins might potentially rise into the low 20% range this Q4.

“We believe as TSLA delivers steady cash flow, a new group of investors will begin taking positions, helping drive shares higher. We are looking to solid Model 3 deliveries and GM plus announcement of China factory financing as catalysts into early 2019,” he said.

Oppenheimer’s Outperform rating and $418 price target on Tesla stock seems to have fostered positive sentiment among the company’s investors. As of writing, Tesla shares are largely maintaining their gains, trading +0.20% at $367.50 per share.

Tesla has received several votes of confidence from Wall Street recently. This month alone, the company received a price target of $420 per share from CFRA, an independent investment research company, as well as a “Buy” rating and $450 price target from Jefferies Financial Group. Piper Jaffray further noted that if Tesla maintains its momentum, the company could very well find itself within striking distance of a short squeeze. All of these firms have mentioned Tesla’s improving fundamentals as a driver for their optimistic outlook on the electric car maker.

Tesla’s core businesses are expected to see a notable improvement in the coming quarters, with Elon Musk stating that the company would be focusing on the introduction of projects like the Model Y SUV and the Tesla pickup truck, as well as the wide rollout of products like the Solar Roof tiles. The Model 3’s entrance into the international markets is also expected to bode well for the company.

In a way, the current optimism surrounding Tesla’s stock could be summarized by the comments of Pierre Ferragu of New Street Research, who recently took a tour of the Fremont factory. In a note to the firm’s clients, Ferragu described Tesla’s Model 3 ramp as a learning experience for the company — one which bodes well for Tesla’s future endeavors.

“By shooting way too high, Tesla failed on its original plan, but achieved a world-class result. The next production sites will be much more efficient, and will ramp very rapidly,” he said.

Disclosure: I have no ownership in shares of TSLA and have no plans to initiate any positions within 72 hours.

The post Oppenheimer raises Tesla (TSLA) price target to $418 amid Q4’s positive Model 3 outlook appeared first on TESLARATI.com.


Source: https://www.teslarati.com/tesla-tsla-outperform-rating-418-price-target-oppenheimer-q4-model-3-outlook/


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Please Help Support BeforeitsNews by trying our Natural Health Products below!


Order by Phone at 888-809-8385 or online at https://mitocopper.com M - F 9am to 5pm EST

Order by Phone at 866-388-7003 or online at https://www.herbanomic.com M - F 9am to 5pm EST

Order by Phone at 866-388-7003 or online at https://www.herbanomics.com M - F 9am to 5pm EST


Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!

HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation.

Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.

MitoCopper - Bioavailable Copper destroys pathogens and gives you more energy. (See Blood Video)

Oxy Powder - Natural Colon Cleanser!  Cleans out toxic buildup with oxygen!

Nascent Iodine - Promotes detoxification, mental focus and thyroid health.

Smart Meter Cover -  Reduces Smart Meter radiation by 96%! (See Video).

Report abuse

    Comments

    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    MOST RECENT
    Load more ...

    SignUp

    Login

    Newsletter

    Email this story
    Email this story

    If you really want to ban this commenter, please write down the reason:

    If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.